Acute Optic Neuritis
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Pharmacokinetics, Safety and Tolerability of Single Doses of BIIB033 (Opicinumab) Produced by 2 Manufacturing Processes (NCT02833142) | Biogen | 2016-07-01 |
| Long-Term Assessment of Remyelinating Therapy (NCT02657915) | Biogen | 2016-03-10 |
| BIIB033 In Acute Optic Neuritis (AON) (NCT01721161) | Biogen | 2012-12-01 |
Track Acute Optic Neuritis automatically
Every clearance here is in the API, with alerts when new ones post.